EBR Systems, Inc. (EBR.AX)
ASX · AUD · Healthcare · Medical Devices
A$0.125 (-7.41%) as of
Key statistics
- Market cap
- 94.17M
- Forward P/E
- -1.09
- EPS (TTM)
- -0.1900
- Dividend yield
- 0.00%
- 52-week range
- 0.1200 – 1.2700
- Beta
- 0.50
- Revenue (TTM)
- 6.45M
- Profit margin
- 0.00%
- Analyst target
- A$0.958419
- Volume
- 2.21M
About EBR Systems, Inc.
EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. It offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of leads; and stimulation of the left ventricular endocardium for cardiac resynchronization therapy (SOLVE-CRT), an investigational device exemption. The company was incorporated in 2003 and is headquartered in Sunnyvale, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Sunnyvale, CA, United States
- Employees
- 135
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.